GF Life Science

Suwon, South Korea Founded: 2002 • Age: 24 yrs
Cosmetics and related ingredients are developed for the beauty sector.
Annual revenue $11.4M Latest available
Total funding - Funding intelligence
Employees 80 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About GF Life Science

GF Life Science is a company based in Suwon (South Korea) founded in 2002. The company has 80 employees as of December 31, 2024. GF Life Science offers products and services including Skin Microbiome Research and Clinical Trials.

  • Headquarter Suwon, South Korea
  • Employees 80 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Gfc Life Science Co., Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $11.39 M (USD)
    8.88
    as on Dec 31, 2024
  • Net Profit
    -$4.03 M (USD)
    -382.79
    as on Dec 31, 2024
  • EBITDA
    $2.23 M (USD)
    45.61
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    80

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of GF Life Science

GF Life Science is a publicly listed company on the KRX with ticker symbol 388610 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 388610 · Sector: Health technology · South Korea

Products & Services of GF Life Science

GF Life Science offers a comprehensive portfolio of products and services, including Skin Microbiome Research and Clinical Trials.

Product name locked
Category locked
Primary

Research on Skin Microbiome is conducted using metadata-based methods and strain libraries

Product name locked
Category locked
Locked

Trials for safety and efficacy of cosmetic products are carried out by dermatologists

Funding Insights of GF Life Science

Premium access

Detailed funding history for GF Life Science

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by GF Life Science

Investments
Premium access

Investment portfolio details for GF Life Science

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - GF Life Science

Premium access

Detailed financials for GF Life Science

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Gf Life Science Comparisons

GF Life Science Primary company
Description
Cosmetics and related ingredients are developed for the beau...
Location
Suwon, South Korea
Founded Year
2002
Annual Revenue
$11.39 M (USD)
Net Profit
-$4.03 M (USD)
EBITDA
$2.23 M (USD)
Employees
80
As of 2024
Premium access

Peer comparison for GF Life Science

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of GF Life Science

Premium access

Detailed competitors of GF Life Science

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Gf Life Science

Premium access

Complete news archive for GF Life Science

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GF Life Science

GF Life Science was founded in 2002.

GF Life Science is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.

Michael Kang is the current CEO of GF Life Science.

As of Dec 31, 2024, the latest employee count at GF Life Science is 80.

Annual revenue of GF Life Science is $11.39M as on Dec 31, 2024.

GF Life Science was established in 2002 in Suwon-si, South Korea. Operations are centered on the cosmetics industry, where ingredients and products for beauty applications are developed. The company is led by CEO Michael Kang. Focus is placed on research and formulation processes to support cosmetic manufacturing. Activities are conducted primarily in the South Korean market, with an online presence via gfcos.co.kr.

GF Life Science offers Skin Microbiome Research and Clinical Trials.

Yes, GF Life Science is publicly traded on KRX under the ticker symbol 388610.

The ticker symbol of GF Life Science is 388610 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available